COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives

Trends in Molecular Medicine

Volumn 26, Issue 5, 2020, Pages 483-495

  Sun, Jiumeng ^a   He, Wan Ting ^a   Wang, Lifang ^b   Lai, Alexander ^c   Ji, Xiang ^d   Zhai, Xiaofeng ^a   Li, Gairu ^a   Suchard, Marc A ^d   Tian, Jin ^e   Zhou, Jiyong ^f   Veit, Michael ^g   Su, Shuo ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c KENTUCKY STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e INSTITUTE OF PLANT PROTECTION   (China)

^f ZHEJIANG UNIVERSITY   (China)

^g FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; VIRUS SPIKE PROTEIN; VIRUS RECEPTOR;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CORONAVIRUS DISEASE 2019; EPIDEMIC; EVOLUTION; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRAL TROPISM; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; BAT; BETACORONAVIRUS; CORONAVIRUS INFECTION; GENETICS; INTERDISCIPLINARY COMMUNICATION; PANDEMIC; VETERINARY MEDICINE; VIROLOGY; VIRUS PNEUMONIA;

ANIMALS; BETACORONAVIRUS; CHIROPTERA; CORONAVIRUS INFECTIONS; HUMANS; INTERDISCIPLINARY COMMUNICATION; PANDEMICS; PNEUMONIA, VIRAL; RECEPTORS, VIRUS;

EID: 85082016518     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2020.02.008     Document Type: Review

References (85)

1. Gorbalenya, A.E., et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses – a statement of the Coronavirus Study Group. bioRxiv, 2020 Published online February 11, 2020. https://doi.org/10.1101/2020.02.07.937862.
2. Resta, S., et al. Isolation and propagation of a human enteric coronavirus. Science 4717 (2018), 978–981.
3. Arabi, Y.M., et al. Middle East Respiratory Syndrome. N. Engl. J. Med. 376 (2017), 584–594.
4. Zhong, N.S., et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 362 (2003), 1353–1358.
5. Drosten, C., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003), 1967–1976.
6. Guan, Y., et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302 (2003), 276–278.
7. Song, H.D., et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 2430–2435.
8. Cohen, J., et al. New SARS-like virus in China triggers alarm. Science 6475 (2019), 234–235.
9. Woo, P.C., et al. Discovery of seven novel mammalian and avian coronaviruses in the genus Deltacoronavirus supports bat coronaviruses as the gene source of Alphacoronavirus and Betacoronavirus and avian coronaviruses as the gene source of Gammacoronavirus and Deltacoronavirus. J. Virol. 86 (2012), 3995–4008.
10. Chinese SARS Molecular Epidemiology Consortium, Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303 (2004), 1666–1669.
11. He, B., et al. Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China. J. Virol. 88 (2014), 7070–7082.
12. Li, Q., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N. Engl. J. Med., 2020 Published online January 29, 2020. https://doi.org/10.1056/NEJMoa2001316.
13. Wang, D., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020 Published online February 7, 2020. https://doi.org/10.1001/jama.2020.1585.
14. Chan, J.F-W., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395 (2020), 514–523.
15. Yang, Y., et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv, 2020 Published online February 21, 2020. https://doi.org/10.1101/2020.02.10.20021675.
16. Kang, M., et al. Evidence and characteristics of human-to-human transmission of SARS-CoV-2. medRxiv, 2020 Published online February 17, 2020. https://doi.org/10.1101/2020.02.03.20019141.
17. Liu, Y.-C., et al. A locally transmitted case of SARS-CoV-2 infection in Taiwan. N. Engl. J. Med., 2020 Published online February 12, 2020. https://doi.org/10.1056/NEJMc2001573.
18. Chang, D., et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA, 2020 Published online February 7, 2020. https://doi.org/10.1001/jama.2020.1623.
19. Li, L., et al. An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19). Zhonghua Liu Xing Bing Xue Za Zhi 41 (2020), 139–144.
20. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 41 (2020), 145–151.
21. Guan, W.-j., et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv, 2020 Published online February 9, 2020. https://doi.org/10.1101/2020.02.06.20020974.
22. Lipsitch, M., et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 300 (2003), 1966–1970.
23. Riley, S., et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 300 (2003), 1961–1966.
24. Breban, R., et al. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 382 (2013), 694–699.
25. Chowell, G., et al. Model parameters and outbreak control for SARS. Emerg. Infect. Dis. 10 (2004), 1258–1263.
26. Swerdlow, D.L., Finelli, L., Preparation for possible sustained transmission of 2019 novel coronavirus: lessons From previous epidemics. JAMA, 2020 Published online February 11, 2020. https://doi.org/10.1001/jama.2020.1960.
27. Park, J.E., et al. MERS transmission and risk factors: a systematic review. BMC Public Health, 18, 2018, 574.
28. 0). Emerg. Infect. Dis. 25 (2019), 1–4.
29. Chen, N., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513.
30. Pongpirul, W.A., et al. Journey of a Thai taxi driver and novel coronavirus. N. Engl. J. Med., 2020 Published online February 12, 2020. https://doi.org/10.1056/NEJMc2001621.
31. Bastola, A., et al. The first 2019 novel coronavirus case in Nepal. Lancet Infect. Dis. 20 (2020), 279–280.
32. Holshue, M.L., et al. First case of 2019 novel coronavirus in the United States. N Engl. J. Med., 2020 Published online January 31, 2020. https://doi.org/10.1016/S1473-3099(20)30067-0.
33. Huang, C., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497-506.
34. Chen, H., et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 20, 30360-30363.
35. Xu, X., et al. Imaging features of 2019 novel coronavirus pneumonia. Eur. J. Nucl. Med. Mol. Imaging, 2020 Published online February 14, 2020. https://doi.org/10.1007/s00259-020-04720-2.
36. Lin, X., Gong, Z., Novel coronavirus pneumonia outbreak in 2019: computed tomographic findings in two cases. Korean J. Radiol. 21 (2020), 365–368.
37. Wei, M., et al. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA, 2020 Published online February 14, 2020. https://doi.org/10.1001/jama.2020.2131.
38. Hoehl, S., et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N. Engl. J. Med., 2020 Published online February 18, 2020. https://doi.org/10.1056/NEJMc2001899.
39. Zhu, H., et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl. Pediatr. 9 (2020), 51–60.
40. Anderson, R.M., et al. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 359 (2004), 1091–1105.
41. Chowell, G., et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med., 13, 2015, 210.
42. Zhou, P., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020 Published online February 3, 2020. https://doi.org/10.1038/s41586-020-2012-7.
43. Wu, F., et al. A new coronavirus associated with human respiratory disease in China. Nature, 2020 Published online February 3, 2020. https://doi.org/10.1038/s41586-020-2008-3.
44. Li, G., et al. Origin, genetic diversity, and evolutionary dynamics of novel porcine circovirus 3. Adv. Sci. (Weinh), 5, 2018, 1800275.
45. Huang, Y.-W., et al. Origin, evolution, and genotyping of emergent porcine epidemic diarrhea virus strains in the United States. mBio, 4, 2013, e00737-00713.
46. Tao, Y., et al. Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history. J. Virol., 2017, e01953-16.
47. Yang, L., et al. Broad cross-species infection of cultured cells by bat HKU2-related swine acute diarrhea syndrome coronavirus and identification of its replication in murine dendritic cells in vivo highlight its potential for diverse interspecies transmission. J. Virol., 93, 2019, e01448-19.
48. Karakus, U., et al. MHC class II proteins mediate cross-species entry of bat influenza viruses. Nature 7746 (2019), 109–112.
49. He, W., et al. Genetic analysis and evolutionary changes of porcine circovirus 2. Mol. Phylogenet. Evol., 139, 2019, 106520.
50. Chen, W., et al. SARS-associated coronavirus transmitted from human to pig. Emerg. Infect. Dis. 11 (2005), 446–448.
51. Hu, D., et al. Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats. Emerg. Microbes Infect., 7, 2018, 154.
52. Lam, T.T.-Y., et al. Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China. bioRxiv, 2020 Published online February 18, 2020. https://doi.org/10.1101/2020.02.13.945485.
53. Menachery, V.D., et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat. Med. 21 (2015), 1508–1513.
54. Paraskevis, D., et al. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect. Genet. Evol., 79, 2020, 104212.
55. Luk, H.K.H., et al. Molecular epidemiology, evolution and phylogeny of SARS coronavirus. Infect. Genet. Evol. 71 (2019), 21–30.
56. Wong, M.C., et al. Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019. bioRxiv, 2020 Published online February 13, 2020. https://doi.org/10.1101/2020.02.07.939207.
57. Xiao, K., et al. Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins. bioRxiv, 2020 Published online February 20, 2020. https://doi.org/10.1101/2020.02.17.951335.
58. Liu, P., et al. Are pangolins the intermediate host of the 2019 novel coronavirus (2019-nCoV)?. bioRxiv, 2020 Published online February 20, 2020. https://doi.org/10.1101/2020.02.18.954628.
59. Lu, R., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 (2020), 565–574.
60. Hui, K.P., et al. Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract. Eur. Respir. J., 49, 2017, 1601710.
61. Wrapp, D., et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 2020 Published online February 19, 2020. https://doi.org/10.1126/science.abb2507.
62. Sun, C., et al. SARS-CoV-2 and SARS-CoV spike-RBD structure and receptor binding comparison and potential implications on neutralizing antibody and vaccine development. bioRxiv, 2020 Published online February 20, 2020. https://doi.org/10.1101/2020.02.16.951723.
63. Li, F., Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 3 (2016), 237–261.
64. Cui, J., et al. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17 (2019), 181–192.
65. Lu, G., et al. Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol. 23 (2015), 468–478.
66. Millet, J.K., Whittaker, G.R., Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 202 (2015), 120–134.
67. Hoffmann, M., et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv, 2020 Published online January 31, 2020. https://doi.org/10.1101/2020.01.31.929042.
68. Coutard, B., et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res., 176, 2020, 104742.
69. Walls, A.C., et al. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. bioRxiv, 2020 Published online February 20, 2020. https://doi.org/10.1101/2020.02.19.956581.
70. Deng, Y., et al. Structures and polymorphic interactions of two heptad-repeat regions of the SARS virus S2 protein. Structure 14 (2006), 889–899.
71. Heald-Sargent, T., Gallagher, T., Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses 4 (2012), 557–580.
72. Lan, J., et al. Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor. bioRxiv, 2020 Published online February 20, 2020. https://doi.org/10.1101/2020.02.19.956235.
73. Li, F., et al. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309 (2005), 1864–1868.
74. Zumla, A., et al. Coronaviruses - drug discovery and therapeutic options. Nat. Rev. Drug Discov. 15 (2016), 327–347.
75. Xia, S., Yan, L., A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci. Adv., 5, 2019, eaav4580.
76. Gadalla, M.R., Veit, M., Toward the identification of ZDHHC enzymes required for palmitoylation of viral protein as potential drug targets. Expert Opin. Drug Discov. 15 (2020), 159–177.
77. Wang, N., et al. Structural definition of a neutralization-sensitive epitope on the MERS-CoV S1-NTD. Cell Rep. 28 (2019), 3395–3405.
78. Letko, M., et al. Adaptive evolution of MERS-CoV to species variation in DPP4. Cell Rep. 24 (2018), 1730–1737.
79. Zhang, S., et al. Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein. Cell Rep. 24 (2018), 441–452.
80. Su, S., et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 24 (2016), 490–502.
81. Zhou, P., et al. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature 556 (2018), 255–258.
82. Hu, B., et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog., 13, 2017, e1006698.
83. Katoh, K., et al. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 30 (2002), 3059–3066.
84. Kumar, S., et al. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33 (2016), 1870–1874.
85. Stamatakis, A., RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30 (2014), 1312–1313.